NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/13/2024
Back to search
Official data from USPTO
TACTOGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
02/13/2024
Trademark type
Combined
Nice classes
5, 42
Filing date
09/25/2020
Registration date
02/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/13/2024
Last transaction
02/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/13/2023
First use in commerce
06/13/2023
Drawing code
3
Owner type
03
Owner location
Palo Alto, CA, US
Examiner
HAN, DAWN L
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the design of a single-line hexagon with parallel left and right sides and its bottom vertex being a greater distance from the center than its top vertex. Below this design appears the wording "TACTOGEN" in stylized font.
Holders and representatives
Holders
Tactogen Inc
Tactogen Inc
Representatives
Graham M Pechenik CALYX LAW
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for pharmaceutical or medical purposesfor treatment of central nervous system diseases and disorders and for improvement of central nervous system health and functioning; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the treatment and prevention of mental health disorders; Pharmaceuticalspsychotropics
Class 42
Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing a website featuring educational information in the field of clinical research; Scientific research; Testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
41 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/13/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/10/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/09/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/08/2024
EX5G
SOU EXTENSION 5 GRANTED
01/08/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/08/2024
IUAF
USE AMENDMENT FILED
12/15/2023
EXT5
SOU EXTENSION 5 FILED
12/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2023
EISU
TEAS STATEMENT OF USE RECEIVED
12/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/16/2023
EX4G
SOU EXTENSION 4 GRANTED
06/14/2023
EXT4
SOU EXTENSION 4 FILED
06/14/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/14/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2022
EX3G
SOU EXTENSION 3 GRANTED
12/15/2022
EXT3
SOU EXTENSION 3 FILED
12/15/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/17/2022
EX2G
SOU EXTENSION 2 GRANTED
06/15/2022
EXT2
SOU EXTENSION 2 FILED
06/15/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/15/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2021
EX1G
SOU EXTENSION 1 GRANTED
12/15/2021
EXT1
SOU EXTENSION 1 FILED
12/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/16/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/16/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/16/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/16/2021
DOCK
ASSIGNED TO EXAMINER
02/15/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2020
NWAP
NEW APPLICATION ENTERED
09/29/2020
Continuous trademark protection
Get notified about every new filing that threatens TACTOGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.